Eikelboom - Evidence from the Randomized Trials - Figure 15
RE-MEDY: VTE or Related Death
As was the case in RE-COVER I. the result for the primary outcome of RE-MEDY for the initial treatment of acute VTE
References
[9] Schulman S, Kearon C, Kakkar AK, et al; for the RE-MEDY and the RE-SONATE Trials Investigators. Extended use of dabigatran, warfarin, or placebo in venous thromboembolism. N Engl J Med. 2013;368:709-718.